The rules for Medicare Advantage are changing, and the impact goes far beyond reimbursement rates. Starting in 2027, CMS is proposing a fundamental shift: diagnoses will only count for risk adjustment if they are tied to an actual patient encounter. That means retrospective chart reviews alone will no longer protect revenue. Under the CMS 2027 Medicare Advantage changes, documentation at the point of care becomes the difference between capturing value and losing it.
We put together a short, practical white paper to break down what this means in real terms, where organizations are most exposed, and what to do now to prepare. If you’re responsible for clinical performance, documentation, or financial outcomes, this is worth a read. The organizations that act now will win under the 2027 model. The ones that delay will lose revenue, margin, and control.
